Ascletis Pharma Inc. (HKG:1672)
Hong Kong
· Delayed Price · Currency is HKD 15.53
+0.80 (5.43%)
Mar 10, 2026, 1:02 PM HKT
Ascletis Pharma Revenue
Ascletis Pharma had revenue of 1.08M CNY in the half year ending June 30, 2025, a decrease of -97.68%. This brings the company's revenue in the last twelve months to 2.36M, down -76.57% year-over-year. In the year 2024, Ascletis Pharma had annual revenue of 1.28M, down -97.73%.
Revenue (ttm)
2.36M CNY
Revenue Growth
-76.57%
P/S Ratio
6,033.93
Revenue / Employee
11.37K CNY
Employees
208
Market Cap
15.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Keymed Biosciences | 955.73M |
| Ascentage Pharma Group International | 428.02M |
| Zai Lab | 3.58B |
| Everest Medicines | 932.82M |
| HBM Holdings | 908.35M |
| Shanghai Haohai Biological Technology | 2.75B |
| PegBio | -4.25M |
| InnoCare Pharma | 1.56B |